JP2016518317A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518317A5
JP2016518317A5 JP2016500700A JP2016500700A JP2016518317A5 JP 2016518317 A5 JP2016518317 A5 JP 2016518317A5 JP 2016500700 A JP2016500700 A JP 2016500700A JP 2016500700 A JP2016500700 A JP 2016500700A JP 2016518317 A5 JP2016518317 A5 JP 2016518317A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
compound according
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500700A
Other languages
English (en)
Japanese (ja)
Other versions
JP6506248B2 (ja
JP2016518317A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021038 external-priority patent/WO2014149819A1/en
Publication of JP2016518317A publication Critical patent/JP2016518317A/ja
Publication of JP2016518317A5 publication Critical patent/JP2016518317A5/ja
Application granted granted Critical
Publication of JP6506248B2 publication Critical patent/JP6506248B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500700A 2013-03-14 2014-03-06 二環式鎮痛化合物 Expired - Fee Related JP6506248B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781580P 2013-03-14 2013-03-14
US61/781,580 2013-03-14
PCT/US2014/021038 WO2014149819A1 (en) 2013-03-14 2014-03-06 Bicyclic analgesic compounds

Publications (3)

Publication Number Publication Date
JP2016518317A JP2016518317A (ja) 2016-06-23
JP2016518317A5 true JP2016518317A5 (enExample) 2017-04-13
JP6506248B2 JP6506248B2 (ja) 2019-04-24

Family

ID=51530018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500700A Expired - Fee Related JP6506248B2 (ja) 2013-03-14 2014-03-06 二環式鎮痛化合物

Country Status (8)

Country Link
US (6) US9447026B2 (enExample)
EP (1) EP2970104B1 (enExample)
JP (1) JP6506248B2 (enExample)
KR (1) KR102243637B1 (enExample)
AR (1) AR095036A1 (enExample)
CA (1) CA2903431C (enExample)
TW (1) TWI630194B (enExample)
WO (1) WO2014149819A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102243637B1 (ko) 2013-03-14 2021-04-26 리커리엄 아이피 홀딩스, 엘엘씨 바이사이클릭 진통 화합물
EP3080072A4 (en) 2013-12-12 2017-07-19 Kalyra Pharmaceuticals, inc. Bicyclic alkyl compounds and synthesis
WO2015134710A1 (en) 2014-03-07 2015-09-11 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
WO2016044331A1 (en) * 2014-09-17 2016-03-24 Kalyra Pharmaceuticals, Inc. Bicyclic compounds
HUE049481T2 (hu) 2015-04-03 2020-09-28 Recurium Ip Holdings Llc Spirociklusos vegyületek
WO2017160926A1 (en) * 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds
CN109890827A (zh) 2016-10-05 2019-06-14 芝诺罗耶尔蒂里程碑有限责任公司 螺环化合物
MX389668B (es) * 2017-05-15 2025-03-20 Recurium Ip Holdings Llc Compuestos biciclo[1.1.1]pentilo sustituidos y uso de los mismos para el tratamiento del dolor y fiebre.
MA49858A (fr) 2017-08-09 2021-04-28 Denali Therapeutics Inc Composés, compositions et procédés
DK3676297T3 (da) 2017-09-01 2023-08-14 Denali Therapeutics Inc Forbindelser, sammensætninger og fremgangsmåder
US11478461B2 (en) 2018-04-19 2022-10-25 Merck Sharp & Dohme Llc [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
SG11202108552QA (en) 2019-02-13 2021-09-29 Denali Therapeutics Inc Compounds, compositions and methods
MA54959A (fr) 2019-02-13 2021-12-22 Denali Therapeutics Inc Composés, compositions et procédés
WO2026004939A1 (ja) * 2024-06-28 2026-01-02 キッセイ薬品工業株式会社 ジ置換ビシクロ[1.1.1]ペンタン化合物

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54795A (en) * 1978-05-26 1980-10-26 Yeda Res & Dev Analgesic compositions comprising substituted bicyclic and spiroaliphatic amines and certain novel compounds of these types
JPH04500663A (ja) 1988-06-03 1992-02-06 ザ ユニヴァーシティー オブ テキサス システム [1.1.1]プロペランに基づく化合物と方法
AU626949B2 (en) 1988-12-06 1992-08-13 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
US5262417A (en) 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
EP0447484A1 (en) 1988-12-06 1991-09-25 The Upjohn Company Antibacterial quinolone compounds
CZ20003355A3 (cs) 1998-03-17 2002-05-15 Pfizer Products Inc. Bicyklo[2,2,1]heptany a příbuzné sloučeniny, farmaceutické kompozice a způsoby léčení na jejich bázi
AU3898000A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of neuropathic pain or fibromyalgia
DE10025946A1 (de) 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
MXPA02010764A (es) 2000-05-31 2003-03-10 Warner Lambert Co Combinaciones de un antagonista del receptor endotelina y un compuesto antiepileptico que tiene propiedades para aliviar el dolor o analgesico.
DE10164348A1 (de) 2001-12-28 2003-07-17 Basf Ag Verfahren zur Herstellung von 1-Methoypropanol-2
BRPI0417267A (pt) 2003-12-22 2007-04-17 Pfizer derivados de triazol como antagonistas de vasopressina
EP1789028A2 (en) 2004-08-24 2007-05-30 Neuromolecular Pharmaceuticals Inc Compositions for treating nociceptive pain
US7763607B2 (en) 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
JP2008120797A (ja) 2006-10-19 2008-05-29 Dainippon Sumitomo Pharma Co Ltd N−置換フェニルアセトアミド誘導体からなる医薬
RU2468011C2 (ru) 2006-12-27 2012-11-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолина и изохинолинона
JP4523073B2 (ja) 2007-02-06 2010-08-11 ファイザー・インク 癌を治療するためのHSP−90阻害剤としての2−アミノ−5,7−ジヒドロ−6H−ピロロ[3,4−d]ピリミジン誘導体
DE602008005928D1 (de) 2007-10-01 2011-05-12 Comentis Inc 1h-indol-3-carbonsäure-chinuclidin-4-ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
CA2724998A1 (en) 2008-06-18 2009-12-23 Pfizer Limited Nicotinamide derivatives
EP2477963A4 (en) 2009-09-18 2013-02-27 Zalicus Pharmaceuticals Ltd ARYLSULFON DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
US20130237559A1 (en) 2010-06-30 2013-09-12 Ronnie Ortiz Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
BR112013008240A2 (pt) 2010-10-08 2017-12-12 Abbvie Inc compostos de furo [3-2-d] pirimidina
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為mPGES-1抑制物的三環化合物
PE20141050A1 (es) 2011-04-05 2014-08-30 Pfizer Ltd Inhibidores de quinasa relacionados con pirrolo (2,3-d) pirimidina tropomiosina
AU2012245387C1 (en) * 2011-04-22 2016-05-05 Signal Pharmaceuticals, Llc Substituted Diaminocarboxamide and Diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
RS54526B1 (sr) 2011-04-22 2016-06-30 Pfizer Inc. Upotreba derivata pirazolospiroketona kao inhibitora acetil-coa karboksilaze
PH12013502670A1 (en) 2011-08-12 2016-07-29 Nissan Chemical Ind Ltd Tricyclic heterocyclic compounds and jak inhibitors
US9326973B2 (en) 2012-01-13 2016-05-03 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
ES2656972T3 (es) 2012-02-23 2018-03-01 Vanderbilt University Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4
WO2013131018A1 (en) 2012-03-02 2013-09-06 Zalicus Pharmaceuticals Ltd. Biaryl inhibitors of the sodium channel
CN104244936A (zh) 2012-04-27 2014-12-24 日本脏器制药株式会社 镇痛剂
KR102243637B1 (ko) 2013-03-14 2021-04-26 리커리엄 아이피 홀딩스, 엘엘씨 바이사이클릭 진통 화합물
US20160076098A1 (en) 2013-04-12 2016-03-17 Drexel University Methods of diagnosing and treating chronic pain
WO2014206922A1 (en) 2013-06-28 2014-12-31 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines and their use as mnk1 and/or mnk2 kinase inhibitors
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
BR112016002638A2 (pt) 2013-08-12 2017-08-01 Hoffmann La Roche novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório
RU2019131017A (ru) 2013-10-21 2019-11-25 Мерк Патент Гмбх Соединения гетероарила в качестве ингибиторов btk и их применение
CN103588672A (zh) 2013-10-28 2014-02-19 史克勇 一种治疗癌性疼痛的药物
CN103588668A (zh) 2013-10-28 2014-02-19 史克勇 化合物
EP3080072A4 (en) 2013-12-12 2017-07-19 Kalyra Pharmaceuticals, inc. Bicyclic alkyl compounds and synthesis
RU2016129380A (ru) 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
WO2015134710A1 (en) 2014-03-07 2015-09-11 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
WO2015157122A1 (en) 2014-04-11 2015-10-15 The University Of North Carolina At Chapel Hill Mertk-specific pyrazolopyrimidine compounds
US20170197939A1 (en) 2014-04-15 2017-07-13 Pfizer Inc. Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety
BR112016024533A8 (pt) 2014-04-24 2021-03-30 Novartis Ag derivados de amino pirazina como inibidores de fosfatidilinositol 3-cinase ou sal, seu uso, e composição e combinação farmacêuticas
EP3174859B1 (en) 2014-07-31 2020-04-29 INSERM - Institut National de la Santé et de la Recherche Médicale Flt3 receptor antagonists
WO2016044331A1 (en) 2014-09-17 2016-03-24 Kalyra Pharmaceuticals, Inc. Bicyclic compounds
WO2017160926A1 (en) 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Analgesic compounds

Similar Documents

Publication Publication Date Title
JP2016518317A5 (enExample)
JP2017514910A5 (enExample)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
JP2016507581A5 (enExample)
MY187617A (en) Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof
JP2016540742A5 (enExample)
JP2014526533A5 (enExample)
JP2013032389A5 (enExample)
PH12015502524B1 (en) New somatostatin receptor subtype 4 (sstr4) agonists
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
WO2016012965A3 (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
MX353957B (es) Carboxamidas heterociclicas fungicidas.
JP2016536364A5 (enExample)
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
JP2016536363A5 (enExample)
MX2022008434A (es) Herbicidas de piridazinona.
IN2014DN01993A (enExample)
JP2014506907A5 (enExample)
JP2011518833A5 (enExample)
JP2016505614A5 (enExample)
JP2016529319A5 (enExample)
JP2019513745A5 (enExample)
JP2014028916A5 (enExample)
JP2012502111A5 (enExample)
JP2016529315A5 (enExample)